Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probi USA is a leading provider of probiotic solutions and a primary subsidiary of the Swedish biotechnology company Probi AB. The company specializes in the research, development, and large-scale manufacturing of high-quality probiotic strains with clinically documented health benefits. Operating state-of-the-art facilities in the United States, Probi USA offers proprietary delivery technologies such as BIO-tract and LiveBac, which ensure probiotic stability and controlled release. Their product portfolio targets diverse therapeutic areas including digestive health, immune support, and bone density, serving the global dietary supplement and functional food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Probi USA.